| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0008 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.003 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.22 | 0.005 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.094 | 0.005 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.088 | 0.006 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.006 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.006 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | 0.43 | 0.007 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.008 |